Mulmit

Obsidian Therapeutics, Inc.Obsidian Therapeutics, Inc.

OBX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-105,667,000-100,607,000-7.22
2024-12-310-91,255,000-83,109,000-6.47

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-03ROSS ROBERT W.37,653
2026-08-03Norkunas Matthew37,653
2026-08-03Jagasia MadanChief Executive Officer37,653
2026-08-03Barrett Peter37,653
2026-08-03Hagen Heidi37,653
2026-08-03Fardis Maria37,653

8-K events

FiledItems
2026-08-14Financial statements and exhibits
2026-08-03Entry into a material agreement · Completed acquisition or disposition of assets · Results of operations · Unregistered sales of equity securities · Material modification to rights of security holders · Change in certifying accountant · Change in control · Officer or director change · Amendments to charter or bylaws · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…